If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fabrizio Fabrizi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial

Fabrizi, F., Cerutti, R., Garcia-Agudo, R., Bellincioni, C., Porata, G., Frontini, G., Aoufi-Rabih, S. & Messa, P., Jan 1 2020, (Accepted/In press) In : Clinics and Research in Hepatology and Gastroenterology.

Research output: Contribution to journalArticle

  • Eficacia y seguridad de los antivíricos de acción directa para el VHC en la nefropatía crónica de leve a moderada

    Translated title of the contribution: Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney diseaseRidruejo, E., Garcia-Agudo, R., Mendizabal, M., Aoufi-Rabih, S., Dixit, V., Silva, M. & Fabrizi, F., Jan 1 2020, In : Nefrologia. 40, 1, p. 46-52 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population

    Fabrizi, F., Cerutti, R., Nardelli, L., Tripodi, F. & Messa, P., 2020, In : Clinics and Research in Hepatology and Gastroenterology. 44, 1, p. 49-56

    Research output: Contribution to journalArticle

  • La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisis

    Translated title of the contribution: HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysisFabrizi, F., Cerutti, R., Donato, F. M. & Messa, P., Jan 1 2020, (Accepted/In press) In : Revista Clinica Espanola.

    Research output: Contribution to journalReview article